๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up

โœ Scribed by V. A. Boussiotis; G. A. Pangalis

Book ID
114712641
Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
391 KB
Volume
79
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Two-year biochemical, virological, and h
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment
โœ Olle Reichard; Hans Glaumann; Aril Frydรฉn; Gunnar Norkrans; Robert Schvarcz; And ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 551 KB

OLLE REICHARD,l HANS GLAUMA",2'3 h I L FRYDEN? GUNNAR NORKRANS,' ROBERT SCHvARCZ,2 ANDERS SONNERBORG,2'6 ZHI-BING YUN,' AND OLA WEILAND2 Fourteen patients with chronic hepatitis C who had a sustained response to a 60-week interferon alfa-2b treatment course were followed, biochemically and virologi

Biochemical and virological outcome of p
Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients
โœ E K Manesis; C Papaioannou; A Gioustozi; G Kafiri; J Koskinas; S J Hadziyannis ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 194 KB ๐Ÿ‘ 2 views

To compare two interferon (IFN) schedules for the treatment of chronic hepatitis C, we followed 211 patients who received 3 million units IFN-alpha2b thrice weekly for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 patients), with a median follow-up of 3.4 (0.1-8.4) and 4.2 (0.7-8